UAP1 divergent transcript (UAP1-DT)

UAP1 divergent transcript (UAP1-DT) is an RNA gene classified as a long non-coding RNA (lncRNA), transcribed from the genome in the region divergent to the *UAP1* gene[5]. Divergent transcripts are a common feature of mammalian genomes, produced at promoters where transcription initiates in both the sense (coding) and antisense (non-coding) directions[2][4]. While some divergent transcripts are stable and may function as lncRNAs, many have unknown function or are thought to play roles in regulating gene expression; for UAP1-DT, there is no specific evidence tying it to a defined biological function or disease[5]. It is not considered a canonical therapeutic target, does not encode a protein, and there are no known drugs or biomarkers related to its modulation. - According to GeneCards, UAP1-DT is annotated as a non-coding gene with no established function, associated proteins, or known clinical significance[5]. - More generally, divergent lncRNAs such as UAP1-DT may be involved in *cis*- or *trans*-regulation of nearby or distant genes, influencing chromatin structure or transcription, but this has not been specifically demonstrated for UAP1-DT[2][4]. - There is no evidence that interference with UAP1-DT has any therapeutic potential or that it acts through any recognized mechanism of drug action. Given these points, UAP1-DT is properly recognized as a non-coding RNA and not as a therapeutic target. The gene and name are correct, but it does not map to a conventional drug target category.

Other names

UAP1 divergent transcriptUAP1-DT